Bipolar Disorder Market Size, Share, Trends, Growth Outlook

Bipolar Disorder Market is estimated to increase at a growth rate of 4.1% CAGR over the forecast period from 2024 to 2030.

The Bipolar Disorder Market study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Drug Class (Mood stabilizer, Anticonvulsant, Antipsychotic Drug, Antidepressant Drug, Others), By Mechanism of Action (Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitor, Tricyclic Antidepressant Drug, Beta Blockers, Others).

An Introduction to Bipolar Disorder Market in 2024

The Bipolar Disorder market in 2024 witnesses ongoing advancements in diagnosis, treatment, and management approaches for this complex psychiatric condition characterized by recurrent episodes of mania and depression. With improved understanding of bipolar disorder's neurobiological underpinnings, novel pharmacological and psychotherapeutic interventions emerge, offering patients personalized and holistic treatment options. Market dynamics are shaped by the growing recognition of bipolar disorder as a global health concern, driving investments in research, advocacy, and public awareness campaigns. Collaborative efforts between healthcare providers, patient advocacy groups, and pharmaceutical companies aim to address unmet needs, reduce treatment disparities, and improve outcomes for individuals living with bipolar disorder.

Bipolar Disorder Market Trend: Growing Adoption of Digital Therapeutics

A significant trend in the Bipolar Disorder market is the increasing adoption of digital therapeutics as a complement to traditional pharmacological treatments. Digital therapeutics offer evidence-based interventions delivered through mobile apps or online platforms, providing patients with tools for self-management, mood tracking, cognitive behavioral therapy (CBT), and medication adherence. This trend is driven by the need for more accessible and scalable treatment options, as well as the growing acceptance of technology-enabled healthcare solutions.

Bipolar Disorder Market Driver: Rising Awareness and Diagnosis Rates

The primary driver for the Bipolar Disorder market is the rising awareness and diagnosis rates of the condition globally. Increased efforts in mental health advocacy, education, and screening initiatives have led to greater recognition of bipolar disorder symptoms and improved access to mental healthcare services. As a result, more individuals are being accurately diagnosed and seeking treatment, driving the demand for pharmaceuticals, psychotherapy, and other therapeutic interventions for bipolar disorder management.

Bipolar Disorder Market Opportunity: Development of Targeted Therapies

An opportunity in the Bipolar Disorder market lies in the development of targeted therapies that address specific subtypes and symptoms of the disorder. Bipolar disorder encompasses a spectrum of presentations, ranging from manic to depressive episodes, with varying severity and treatment responses among patients. By identifying biomarkers, genetic factors, and neurobiological mechanisms associated with different subtypes of bipolar disorder, pharmaceutical companies can develop personalized treatments that target underlying pathophysiological processes, leading to improved efficacy and outcomes for patients. Collaboration between researchers, clinicians, and pharmaceutical firms is essential to advance the understanding of bipolar disorder heterogeneity and accelerate the development of innovative therapeutic approaches.

Bipolar Disorder Market Segmentation

By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

 

Bipolar Disorder Market Companies

AbbVie Inc
Allergan PLC
AstraZeneca Plc
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc

 

 

Reasons to Buy the Bipolar Disorder Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the Bipolar Disorder Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the Bipolar Disorder Market industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

 

TABLE OF CONTENTS

1 Introduction to 2024 Bipolar Disorder Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global Bipolar Disorder Market Size Outlook, $ Million, 2021 to 2030
3.2 Bipolar Disorder Market Outlook by Type, $ Million, 2021 to 2030
3.3 Bipolar Disorder Market Outlook by Product, $ Million, 2021 to 2030
3.4 Bipolar Disorder Market Outlook by Application, $ Million, 2021 to 2030
3.5 Bipolar Disorder Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of Bipolar Disorder Market Industry
4.2 Key Market Trends in Bipolar Disorder Market Industry
4.3 Potential Opportunities in Bipolar Disorder Market Industry
4.4 Key Challenges in Bipolar Disorder Market Industry

5 Market Factor Analysis
5.1 Competitive Landscape
5.1.1 Global Bipolar Disorder Market Share by Company (%), 2023
5.1.2 Product Offerings by Company
5.2 Porter’s Five Forces Analysis

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global Bipolar Disorder Market Outlook By Segments
7.1 Bipolar Disorder Market Outlook by Segments
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

8 North America Bipolar Disorder Market Analysis And Outlook To 2030
8.1 Introduction to North America Bipolar Disorder Markets in 2024
8.2 North America Bipolar Disorder Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America Bipolar Disorder Market size Outlook by Segments, 2021-2030
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

9 Europe Bipolar Disorder Market Analysis And Outlook To 2030
9.1 Introduction to Europe Bipolar Disorder Markets in 2024
9.2 Europe Bipolar Disorder Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe Bipolar Disorder Market Size Outlook By Segments, 2021-2030
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

10 Asia Pacific Bipolar Disorder Market Analysis And Outlook To 2030
10.1 Introduction to Asia Pacific Bipolar Disorder Markets in 2024
10.2 Asia Pacific Bipolar Disorder Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific Bipolar Disorder Market size Outlook by Segments, 2021-2030
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

11 South America Bipolar Disorder Market Analysis And Outlook To 2030
11.1 Introduction to South America Bipolar Disorder Markets in 2024
11.2 South America Bipolar Disorder Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America Bipolar Disorder Market size Outlook by Segments, 2021-2030
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

12 Middle East And Africa Bipolar Disorder Market Analysis And Outlook To 2030
12.1 Introduction to Middle East and Africa Bipolar Disorder Markets in 2024
12.2 Middle East and Africa Bipolar Disorder Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa Bipolar Disorder Market size Outlook by Segments, 2021-2030
By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others

13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
AbbVie Inc
Allergan PLC
AstraZeneca Plc
Eli Lilly and Company
GlaxoSmithKline Plc
Janssen Pharmaceuticals Inc
Novartis AG
Otsuka Holdings Co. Ltd
Pfizer Inc

14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Drug Class
Mood stabilizer
Anticonvulsant
Antipsychotic Drug
Antidepressant Drug
Others
By Mechanism of Action
Selective Serotonin Reuptake Inhibitor
Serotonin Norepinephrine Reuptake Inhibitor
Tricyclic Antidepressant Drug
Beta Blockers
Others